Insights into the Management of Emerging Infections: Regulating Variant Creutzfeldt-Jakob Disease Transfusion Risk in the UK and the US
2006

Understanding Regulations for Variant Creutzfeldt-Jakob Disease in the UK and US

Sample size: 40 publication Evidence: moderate

Author Information

Author(s): Maya L. Ponte

Primary Institution: University of California San Francisco

Hypothesis

What factors influenced the design of regulations to prevent transfusion transmission of vCJD in the UK and US?

Conclusion

The study found that both scientific evidence and social factors significantly influenced the differing regulations in the UK and US regarding vCJD transfusion risk.

Supporting Evidence

  • Policies were influenced by past experiences with HIV/AIDS.
  • Local urgency in the UK led to quicker policy implementation.
  • Scientific studies were interpreted differently in the US and UK.

Takeaway

This study looked at how different countries made rules to keep people safe from a disease called vCJD, showing that past experiences and local situations really matter.

Methodology

The study involved document searches and interviews with individuals familiar with the decision-making process regarding vCJD regulations.

Potential Biases

Potential biases may arise from the subjective nature of qualitative interviews and the selection of interviewees.

Limitations

The study is based on qualitative data, which may not capture all aspects of the regulatory processes.

Participant Demographics

Participants included government employees and advisory committee members from both the US and UK.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0030342

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication